1. Detection of Low-level EGFR c.2369 C > T (p.Thr790Met) Resistance Mutation in Pre-treatment Non-small Cell Lung Carcinomas Harboring Activating EGFR Mutations and Correlation with Clinical Outcomes
   Linda Ye et al, 2020, Pathology & Oncology Research CrossRef
2. A simple and robust real-time qPCR method for the detection of PIK3CA mutations
   Virginia Alvarez-Garcia et al, 2018, Scientific Reports CrossRef
3. Optimizing the sequencing of tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC)
   Ana C.Z. Gelatti et al, 2019, Lung Cancer CrossRef
4. EGFR T790M Mutation in TKI-Naïve Clinical Samples: Frequency, Tissue Mosaicism, Predictive Value and Awareness on Artifacts
   Elena D. Lavdovskaia et al, 2018, Oncology Research and Treatment CrossRef
5. Synchronous multiple lung cancer consisting of squamous cell carcinoma and adenocarcinoma with de novo T790M EGFR gene mutation
   Gaku Yamaguchi et al, 2018, The Journal of the Japanese Association for Chest Surgery CrossRef
6. Single-cell transcriptional changes associated with drug tolerance and response to combination therapies in cancer
   Alexandre F. Aissa et al, 2021, Nature Communications CrossRef
7. The prognostic role of pretreatment epidermal growth factor receptor T790M mutation in advanced non-small cell lung cancer patients treated with EGFR tyrosine kinase inhibitors
   Guangzhi Ma et al, 2017, Oncotarget CrossRef
8. Novel approaches against epidermal growth factor receptor tyrosine kinase inhibitor resistance
   Carina Heydt et al, 2018, Oncotarget CrossRef
9. Predictive impact of low-frequency pretreatment T790M mutation in patients with EGFR-mutated non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors
   Yoshiya Matsumoto et al, 2020, Lung Cancer CrossRef
10. Nuclease Enrichment and qPCR Detection of Rare Nucleotide Variants
    Ieva Keraite et al, 2023, Clinical Applications of Nucleic Acid Amplification CrossRef
11. Depletion of wild-type target enhances the hybridization-based sensitivity of low-abundant mutation detection by reference capture probes
    Rebekka Van Hoof et al, 2022, Sensors and Actuators B: Chemical CrossRef
12. EGFR T790M ctDNA testing platforms and their role as companion diagnostics: Correlation with clinical outcomes to EGFR-TKIs
    Zhiyong Liang et al, 2017, Cancer Letters CrossRef
13. Comparison of cross-platform technologies for EGFR T790M testing in patients with non-small cell lung cancer
    Xuefei Li et al, 2017, Oncotarget CrossRef
14. Biomarkers in Non-Small Cell Lung Cancers: Indian Consensus Guidelines for Molecular Testing
    Kumar Prabhash et al, 2019, Advances in Therapy CrossRef
15. Origin of the T790M mutation and its impact on the clinical outcomes of patients with lung adenocarcinoma receiving EGFR-TKIs
    Yujie Dong et al, 2019, Pathology - Research and Practice CrossRef